Pharming Group NV (PHAR)

1.177 -0.010 (-0.84%)
Real-time Data EUR Disclaimer

Pharming Group NV Company Profile

Equity Type
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.
Contact Information
Leiden,2333 CR Netherlands
31 71 524 7400
31 71 524 7445
Top Executives
Paul J. Sekhri 63 2015 Independent Non-Executive Chairman
Debora A. Jorn 63 2019 Independent Non-Executive Vice-Chairperson
Sijmen de Vries 62 2008 President, CEO & Executive Director
Leonard Kruimer 64 2021 Independent Non-Executive Director
Jabine van der Meijs 56 2021 Independent Non-Executive Director
Mark Jerome Pykett 58 2020 Independent Non-Executive Director
Barbara Yanni 68 2020 Independent Non-Executive Director
Steven Baert 48 2021 Independent Non-Executive Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.